drugset / Trial / NCT01152671
A Study of RO5024048 in Japanese and Caucasian Healthy Volunteers
RandomizedParallel-groupDouble-blind
Summary
This randomized, double-blind, placebo-controlled study will assess the safety, tolerability and pharmacokinetics of RO5024048. Japanese and Caucasian healthy volunteers will be randomized to receive either single oral doses of RO5024048 or placebo. Follow-up is 7-10 days.
Timeline
- Start
- 2010-06
- Primary completion
- —
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mericitabine | Small molecule | — | Oral |
Indications
No indication recorded.